Pfizer is about to buy Arena Pharmaceuticals for $6.7 billion. Arena is a biopharmaceutical company focused in part on cardiovascular and inflammatory medicines to a global patient cohort.
U.S. Centers for Disease Control and Prevention said Thursday it had received reports of eight cases of myocarditis in children aged 5-11 years who received Pfizer/BioNTech's Covid-19 shot.